Home
>
National Drug Code (NDC)
>
Stalevo
Stalevo - 0078-0545-05 - (carbidopa, levodopa, and entacapone)
Drug Information of Stalevo
| Product NDC: | 0078-0545 |
| Proprietary Name: | Stalevo |
| Non Proprietary Name: | carbidopa, levodopa, and entacapone |
| Active Ingredient(s): | 31.25; 200; 125 mg/1; mg/1; mg/1 & nbsp; carbidopa, levodopa, and entacapone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Stalevo
| Product NDC: | 0078-0545 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021485 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080926 |
Package Information of Stalevo
| Package NDC: | 0078-0545-05 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0545-05) |
NDC Information of Stalevo
| NDC Code | 0078-0545-05 |
| Proprietary Name | Stalevo |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0545-05) |
| Product NDC | 0078-0545 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | carbidopa, levodopa, and entacapone |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20080926 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | CARBIDOPA; ENTACAPONE; LEVODOPA |
| Strength Number | 31.25; 200; 125 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |
